BPH stands for benign prostatic hyperplasia, the medical term for a non-cancerous enlargement of the prostate gland. It affects roughly 50% of men by their 60s and up to 80% by their 80s, making it one of the most common conditions associated with aging in men. The word “benign” means it is not cancer, “prostatic” refers to the prostate, and “hyperplasia” describes an increase in the number of cells.
What Happens Inside the Prostate
The prostate is a walnut-sized gland that sits just below the bladder and wraps around the tube that carries urine out of the body (the urethra). BPH specifically develops in a region called the transition zone, the innermost part of the prostate that directly surrounds the urethra. This location is what makes the condition so disruptive to urination, even though the growth itself is harmless.
At a cellular level, BPH involves the gradual accumulation of smooth muscle cells, gland-lining cells, and connective tissue cells in that transition zone. As men age, signaling loops between these cell types go slightly haywire. Aging cells in the gland lining release chemical signals that stimulate nearby connective tissue cells to produce growth factors, which in turn drive the multiplication of healthy neighboring cells. This feedback cycle causes the tissue mass to slowly expand over years and decades.
A key hormone in this process is dihydrotestosterone (DHT), a more potent form of testosterone produced inside the prostate. DHT binds to receptors in prostate cells and promotes their growth and survival. While DHT is essential for normal prostate development earlier in life, its continued activity in the adult prostate contributes to the pathologic enlargement seen in BPH.
How BPH Causes Urinary Problems
The enlarged prostate creates urinary symptoms through two distinct mechanisms. The first is purely physical: the extra tissue compresses the urethra, narrowing the channel through which urine passes. The second is muscular: the smooth muscle within the prostate becomes overactive, tightening around the urethra and further restricting flow. Both mechanisms increase resistance at the bladder outlet.
Doctors group the resulting symptoms under the umbrella term “lower urinary tract symptoms,” or LUTS. These generally fall into two categories:
- Obstructive symptoms: a weak or intermittent urine stream, straining to urinate, a sense that the bladder hasn’t fully emptied, and dribbling at the end of urination.
- Irritative symptoms: needing to urinate frequently (especially at night), sudden strong urges that are hard to control, and in some cases involuntary leaking.
Not every man with an enlarged prostate develops bothersome symptoms, and symptom severity doesn’t always correlate with prostate size. A moderately enlarged prostate can cause significant obstruction depending on exactly where the growth occurs relative to the urethra.
Who Gets BPH and Why
Age is the single strongest risk factor. Autopsy studies estimate that about 8% of men show microscopic evidence of BPH in their 30s, 50% by their 60s, and 80% by their 80s. The condition is virtually nonexistent before age 30 and nearly universal in very old age.
Beyond aging, hormonal shifts play a central role. As men get older, the balance between testosterone and estrogen changes, and the prostate becomes more sensitive to DHT. Metabolic factors also appear to matter. Research increasingly links BPH to metabolic syndrome, the cluster of conditions that includes insulin resistance, obesity, high blood pressure, and abnormal cholesterol. Men with these metabolic risk factors tend to develop larger prostates and more severe symptoms, suggesting that prostate growth is not driven by hormones alone.
How Symptoms Are Measured
The standard tool for evaluating BPH symptoms is the International Prostate Symptom Score (IPSS), a short questionnaire that covers seven areas: incomplete emptying, urinary frequency, intermittent stream, urgency, weak stream, straining, and nighttime urination. Each question is scored from 0 to 5 based on how often the symptom occurs, producing a total between 0 and 35.
A score of 0 to 7 indicates mild symptoms, 8 to 19 is moderate, and 20 to 35 is severe. This score helps determine whether treatment is necessary and, if so, which approach makes sense. Men with mild symptoms often do well with periodic monitoring alone. Those in the moderate to severe range typically benefit from medication or a procedure.
BPH Is Not Prostate Cancer
One of the most common concerns men have after learning about BPH is whether it means they have, or will develop, prostate cancer. The two conditions are distinct. BPH originates in the transition zone near the urethra, while prostate cancer most commonly arises in the peripheral zone, the outer portion of the gland.
Confusingly, both conditions can raise PSA (prostate-specific antigen) levels in the blood. An enlarged prostate produces more PSA simply because there are more prostate cells, not because anything malignant is happening. This means an elevated PSA reading does not indicate cancer on its own, and some men are diagnosed with cancer despite having a normal PSA. Your doctor may use additional tests, including imaging or a biopsy, to tell the two apart when PSA levels are ambiguous.
Medication Options
Two main classes of medication are used for BPH, each targeting a different mechanism. The first relaxes the smooth muscle in the prostate and bladder neck, reducing the muscular squeeze on the urethra. These medications (called alpha-blockers) typically improve urinary flow within days to weeks and are often the first treatment prescribed for bothersome symptoms.
The second class works by blocking the conversion of testosterone into DHT, effectively shrinking the prostate over time. Because the gland needs months to reduce in size, symptom improvement with these medications is gradual, often taking three to six months to become noticeable. However, they offer a benefit that alpha-blockers do not: they can reduce the long-term risk of the prostate growing large enough to require surgery or cause a complete inability to urinate.
Some men take both types together, especially when symptoms are moderate to severe and the prostate is significantly enlarged.
Procedures for BPH
When medications aren’t enough, or when symptoms are severe from the start, several procedures can physically open up the blocked urethra. The most established is a procedure that uses heat energy to remove excess prostate tissue through the urethra, suitable for prostates up to about 100 grams. It has decades of outcome data and remains the benchmark against which newer options are compared.
Two newer, less invasive alternatives have gained popularity. One uses small permanent implants placed through the urethra to pin back the prostate lobes, physically widening the urethral channel without removing any tissue. It works best for small to medium prostates (up to 100 grams) and has the advantage of preserving sexual function in most men.
The other delivers targeted steam to destroy the obstructing tissue, which the body then gradually reabsorbs. It is suited for prostates up to about 80 grams and can often be performed in an office setting with minimal sedation. Recovery from both newer options is generally faster than from tissue-removal procedures, though long-term retreatment rates tend to be higher.
The choice among these options depends on prostate size, symptom severity, how much the symptoms affect your quality of life, and your priorities around sexual function and recovery time. Current urology guidelines emphasize that surgery should be considered as a first-line option in certain clinical scenarios, not only as a last resort after medications fail.